Minerva Surgical Inc
OTC:UTRS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Minerva Surgical Inc
OTC:UTRS
|
US |
|
MYT Netherlands Parent BV
NYSE:MYTE
|
DE |
|
G
|
Global Health Ltd
NSE:MEDANTA
|
IN |
|
A
|
Accelera Innovations Inc
OTC:ACNV
|
US |
|
N
|
New Relic Inc
F:2NR
|
US |
|
Sparebanken Norge
F:K7I
|
NO |
|
Bank of Ningbo Co Ltd
SZSE:002142
|
CN |
|
Relief Therapeutics Holding SA
SIX:RLF
|
CH |
|
E
|
Energix Renewable Energies Ltd
TASE:ENRG
|
IL |
|
P
|
Peakstone Realty Trust
NYSE:PKST
|
US |
|
B
|
Bank of America Corp
SIX:BAC
|
US |
|
Contextlogic Inc
NASDAQ:LOGC
|
US |
|
M
|
Motherson Sumi Wiring India Ltd
NSE:MSUMI
|
IN |
|
Crown Capital Partners Inc
TSX:CRWN
|
CA |
|
Shanghai Belling Corp Ltd
SSE:600171
|
CN |
|
F
|
Fosun Tourism Group
HKEX:1992
|
CN |
|
CMO Group PLC
LSE:CMO
|
UK |
|
C
|
CSP International Fashion Group SpA
MIL:CSP
|
IT |
|
Pan Global Resources Inc
XTSX:PGZ
|
CA |
Minerva Surgical Inc
Minerva Surgical, Inc. is a medical technology company, which engages in the research, development, manufacture, and commercialization of invasive solutions for uterine healthcare needs of women. The company is headquartered in Santa Clara, California and currently employs 157 full-time employees. The company went IPO on 2021-10-22. The firm has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of abnormal uterine bleeding (AUB) in most uterine anatomies. Its solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. The firm offers a suite of products for the treatment of structural and non-structural causes of AUB in most uterine anatomies. Its devices are utilized by obstetrician-gynecologists (OB/GYNs) across a variety of medical treatment settings, including hospitals, ambulatory surgical centers (ASCs) and physician offices.
Minerva Surgical, Inc. is a medical technology company, which engages in the research, development, manufacture, and commercialization of invasive solutions for uterine healthcare needs of women. The company is headquartered in Santa Clara, California and currently employs 157 full-time employees. The company went IPO on 2021-10-22. The firm has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of abnormal uterine bleeding (AUB) in most uterine anatomies. Its solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. The firm offers a suite of products for the treatment of structural and non-structural causes of AUB in most uterine anatomies. Its devices are utilized by obstetrician-gynecologists (OB/GYNs) across a variety of medical treatment settings, including hospitals, ambulatory surgical centers (ASCs) and physician offices.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
